HORIBA has expanded its compact haematology instrument range with the launch of new models featuring on-board Erythrocyte Sedimentation Rate (ESR) testing. The Yumizen H550E (autoloader), H500E CT (closed tube), and H500E OT (open tube) now offer combined testing for CBC/DIFF with ESR results from whole blood in 60 seconds, enhancing their utility for inflammatory disease […]
Bio-Rad Laboratories, has launched Celselect Slides 2.0, a significant upgrade to their technology for isolating circulating tumour cells (CTCs) from liquid biopsy samples. This latest iteration, compatible with Bio-Rad’s Genesis Cell Isolation System, offers substantial improvements in sample processing capacity and cell capture efficiency.
The European Laboratory Research & Innovation Group (ELRIG) UK and The Protein Society (TPS) have announced a partnership aimed at advancing protein sciences in drug discovery. This collaboration will culminate in a joint conference, ‘Protein Sciences in Drug Discovery’, scheduled for 18-19 November 2024 in Cambridge, UK.
In a move set to advance the lab informatics landscape, Sapio Sciences has launched its Partner Programme. This initiative aims to foster a robust ecosystem of technology vendors, service providers, and resellers, equipping them with essential resources to deliver cutting-edge solutions for scientists.
A new partnership between Surfix Diagnostics, the Netherlands Cancer Institute (NKI), and CRCbioscreen will focus on the validation of novel biomarkers for colorectal cancer (CRC) screening. The collaboration, supported by a PPP grant from the TKI-program Life Sciences & Health of Health~Holland, aims to address the limitations of current screening methods and potentially revolutionise early […]
Munich-based biopharmaceutical company SciRhom GmbH has secured a substantial €63 million (US$70 million) in Series A financing to accelerate the development of its pioneering iRhom2-targeting antibodies for autoimmune disorders. The oversubscribed funding round, co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners, will propel the company’s lead candidate toward clinical proof-of-concept […]
Newcastle-based drug discovery partner Newcells Biotech has appointed Emile Shaffu as Director of Sales. This strategic move aims to strengthen the company’s global market presence and enhance customer support in the field of in vitro models and bespoke assay services.
Cellular Origins, a TTP company specialising in cell and gene therapy (CGT) manufacturing solutions, has announced the acquisition of the Autologous Cell Therapy Industrial Automation (ACTIA) Platform intellectual property. The acquisition is set to augment the company’s existing Constellation™ platform, which was launched in May 2023.
A unique portfolio of neurobiomarker tests The testing landscape for neurological diseases has expanded rapidly in recent years due to the characterisation of many novel biomarkers. With over 15 years of experience in neurological analytics, EUROIMMUN offers an unparalleled portfolio of assays for determination of more than 80 neurobiomarkers in autoimmune diseases, neurological infections and […]
In July 2024, Beckman Coulter Diagnostics announced a €10 million investment and 80 jobs for its site in mid-west Ireland. CLI caught up with Kevin O’Reilly, President of Beckman Coulter Diagnostics, to find out more about the company’s aims, its commitment to the site in Ireland, and how a world-class diagnostics development facility can be […]
May 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.